NaGdF4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts in vivo.
about
Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agentsNanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Self-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy.Controllable in situ synthesis of magnetite coated silica-core water-dispersible hybrid nanomaterials.Geometrically confined ultrasmall gadolinium oxide nanoparticles boost the T(1) contrast ability.Copy number variation analysis by ligation-dependent PCR based on magnetic nanoparticles and chemiluminescence.Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy.Detection of early primary colorectal cancer with upconversion luminescent NP-based molecular probes.Three-dimensional controlled growth of monodisperse sub-50 nm heterogeneous nanocrystals.Rare-Earth-Based Nanoparticles with Simultaneously Enhanced Near-Infrared (NIR)-Visible (Vis) and NIR-NIR Dual-Conversion Luminescence for Multimodal Imaging.NaGdF4:Dy(3+) nanofibers and nanobelts: facile construction technique, structure and bifunctionality of luminescence and enhanced paramagnetic performances.Eu, Gd-Codoped Yttria Nanoprobes for Optical and T₁-Weighted Magnetic Resonance Imaging.Core-Shell Nanostars for Multimodal Therapy and Imaging.A high-sensitivity lanthanide nanoparticle reporter for mass cytometry: tests on microgels as a proxy for cells.Lanthanide-doped luminescent nanoprobes: controlled synthesis, optical spectroscopy, and bioapplications.Upconversion-nanophosphor-based functional nanocomposites.Environmentally responsive MRI contrast agents.Are rare-earth nanoparticles suitable for in vivo applications?Current advances in lanthanide ion (Ln(3+))-based upconversion nanomaterials for drug delivery.Magnetically engineered semiconductor quantum dots as multimodal imaging probes.No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine.Core-shell NaGdF4@CaCO3 nanoparticles for enhanced magnetic resonance/ultrasonic dual-modal imaging via tumor acidic micro-enviroment triggering.One-step synthesis of gradient gadolinium ironhexacyanoferrate nanoparticles: a new particle design easily combining MRI contrast and photothermal therapy.Synthesis and functionalization of NaGdF4:Yb,Er@NaGdF4 core-shell nanoparticles for possible application as multimodal contrast agents.The effect of core and lanthanide ion dopants in sodium fluoride-based nanocrystals on phagocytic activity of human blood leukocytes.Recent advancements in biocompatible inorganic nanoparticles towards biomedical applications.Modifying the size and uniformity of upconversion Yb/Er:NaGdF4 nanocrystals through alkaline-earth doping.Biodegradable Nanoagents with Short Biological Half-Life for SPECT/PAI/MRI Multimodality Imaging and PTT Therapy of Tumors.Hyperbranched polymer mediated size-controlled synthesis of gadolinium phosphate nanoparticles: colloidal properties and particle size-dependence on MRI relaxivity.Sequential growth of CaF2:Yb,Er@CaF2:Gd nanoparticles for efficient magnetic resonance angiography and tumor diagnosis.Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.A versatile 'click chemistry' route to size-restricted, robust, and functionalizable hydrophilic nanocrystals.Water dispersible upconverting nanoparticles: effects of surface modification on their luminescence and colloidal stability.An ultrasmall and metabolizable PEGylated NaGdF4:Dy nanoprobe for high-performance T(1)/T(2)-weighted MR and CT multimodal imaging.A Functional CT Contrast Agent for In Vivo Imaging of Tumor Hypoxia.Ultrasmall NaGdF4 nanodots for efficient MR angiography and atherosclerotic plaque imaging.Differently sized magnetic/upconversion luminescent NaGdF4:Yb,Er nanocrystals: flow synthesis and solvent effects.Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.Potential Clinical Risk of Inflammation and Toxicity from Rare-Earth Nanoparticles in Mice
P2860
Q26824262-A8C7A510-84E6-4603-B4CA-076AD43BB412Q30354652-547111EE-F224-4B34-ADF0-63EF5BD5477DQ30361067-328EBC81-E314-47A7-B26A-7986A6DD3502Q30657442-61B149C0-642C-424E-B32B-A8332A697244Q31040215-95B4009C-5067-4076-86A8-9B0FE2C4E9CBQ34698666-9890ADA0-6124-4600-8143-44EC7E949592Q34811465-2ABABCB2-168C-47E0-9B46-4E6E7D04D9ECQ35676729-77070BB3-33BA-47A5-9102-EB40B343533FQ35867780-6C88A9AA-2E26-4EC9-9549-B22DC935AA9DQ35888418-EA215EBA-379C-4684-BEE1-440EB3FEC4BAQ35898706-72EA76DA-6E9A-4A3B-992F-227D8D93768AQ36155540-6E69BE09-4DE1-403F-9230-9F4CA4831701Q36321344-56DA886D-5385-4E91-8A86-9914143C2B4FQ37427807-A3D5E155-0ABF-464D-ACF2-C7D17CF3C409Q37697422-ABA31C0E-719B-4CB1-AA59-F15247FEA58BQ38115169-40463DC6-AF85-4374-9FFB-91BE7118032EQ38132091-1495D93D-D8FA-49BA-8184-A6D017AD5D4BQ38138098-96C92C7C-5441-4281-9400-94F6EB9382D0Q38194991-782DDB7D-42D9-4E69-BC41-24DA7BC72DCDQ38225630-6AB84829-358C-4CC3-BDEF-67B4EDD4B391Q38245271-1EAFDF4D-5C6C-4955-87E1-F34712A38EE1Q38364473-59F9D625-C60D-4783-8625-367F63764DE1Q38657299-824E6535-9B70-40CB-B441-6C3D67DE9E3CQ38906985-5DB0275D-A17E-4596-8536-BAD9974DFC29Q41594938-30C384B8-9E08-42C1-B60F-04232F89119CQ42321858-6E36AF67-735A-4A40-8E30-C83E0C1398B8Q47195292-C9DFA4E5-5D33-49F3-A9F5-443855C03BA2Q47206805-EA0A95C4-3C1B-4706-96F2-7ABB14071013Q47294407-99445356-E81F-4A83-9589-68BD7F32FAC7Q47328554-A81596DD-B3A2-4926-AED0-67DA158BE646Q47408271-FFA39F2F-7664-4624-942C-BDB3216CEDB6Q47409412-5AE20D95-1EA6-490F-B40C-E7B9EB4C1CEDQ47418591-40089D89-83B0-4868-8999-A69A1AF68B2FQ50443256-FB745FB1-0F7A-40B0-9663-64B1D18E667EQ50937749-BC8DF2FB-5724-40CF-A395-07F570B08816Q51501435-060862EC-08B4-4594-9B7B-FD4F64DBA1D8Q53072951-BB4FCEDE-5A22-469E-A17F-CBFF30E38FE9Q54340775-EFEFC0CB-A8DC-48FA-8FCF-8CEEAAFD8B01Q55073008-66B4D4AD-78C6-47E2-AF49-0E0D0F38E193Q57181810-9E640CC1-6552-4AB0-B6F3-BB648F5A0D96
P2860
NaGdF4 nanoparticle-based molecular probes for magnetic resonance imaging of intraperitoneal tumor xenografts in vivo.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
NaGdF4 nanoparticle-based mole ...... neal tumor xenografts in vivo.
@ast
NaGdF4 nanoparticle-based mole ...... neal tumor xenografts in vivo.
@en
type
label
NaGdF4 nanoparticle-based mole ...... neal tumor xenografts in vivo.
@ast
NaGdF4 nanoparticle-based mole ...... neal tumor xenografts in vivo.
@en
prefLabel
NaGdF4 nanoparticle-based mole ...... neal tumor xenografts in vivo.
@ast
NaGdF4 nanoparticle-based mole ...... neal tumor xenografts in vivo.
@en
P2093
P921
P356
P1433
P1476
NaGdF4 nanoparticle-based mole ...... neal tumor xenografts in vivo.
@en
P2093
Chengyan Dong
Chunyan Liu
Mingyuan Gao
Ruirui Qiao
Xuxia Wang
P304
P356
10.1021/NN304837C
P407
P577
2012-12-07T00:00:00Z